Pure Extracts Hires Adult Recreational Cannabis Sales Agency Cannavolve

VANCOUVER, British Columbia, May 06, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has signed an agreement with Cannavolve Inc. (“Cannavolve”), one of Canada’s premier adult recreational cannabis retail sales agency.

Cannavolve provides a national cannabis sales solution and will handle field-level sales, including in-store product knowledge training for budtenders for Pure Pulls Vapes and Pure Chews. Cannavolve will assist in maximizing the distribution of Pure Extracts’ portfolio of products across Canada by engaging existing relationships with provincial wholesale buyers focused immediately on British Columbia and Alberta.

Pure Extracts CEO, Ben Nikolaevsky, remarked, “With approximately 2,000 licensed cannabis retailers in Canada and over 650 in each of Ontario and Alberta alone, we are pleased to have entered into this sales representation agreement with an established agency like Cannavolve with their boots-on-the-ground presence in every province. There is no substitute for having a regular, in-person, sales presence at the actual point of purchase retail outlet where brand awareness originates.”

Added Trace Hanlon, Partner & Director of Cannavolve, “Our field team, our Co-Founder & Partner Kye Melchert, and I are all extremely excited that Pure Extracts has chosen us as their sales agency. We have a strong track record of building brands in Canada, and we look forward to being a part of Pure Extracts’ path to growth nationally”.

ON BEHALF OF THE BOARD
“Ben Nikolaevsky”
Ben Nikolaevsky
CEO and Director

About Pure Extracts (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ)

Pure Extracts Technology Corp. features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. On September 25, 2020, Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act and the company’s stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020.

Find out more at https://pureextractscorp.com/.

For further information please contact Empire Communications Group at (604) 343-2724.

The CSE has neither approved nor disapproved the contents of this press release.

This news release contains forward-looking statements relating to the future operations of Pure Extracts, and the other statements are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding US expansion and the future plans and objectives of Pure Extracts’, are forward-looking statements and involve risks and uncertainties. A number of factors could cause actual events, performance or results to differ materially from what is projected in forward looking statements. Although we believe that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and we cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements. Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under “Risk Factors” in the Company’s Annual Information Form. The Company does not undertake to update any forward-looking information, except as, and to the extent required by, applicable securities laws.

This news release contains information about potential sales revenue from supply agreements, which may be considered as disclosure of financial outlook under applicable securities laws. Such information is subject to the same assumptions, risk factors, limitations, and qualifications as set forth in the above paragraph. Specifically, estimated sales revenue which may be derived from supply contracts has been calculated based on current wholesale prices and assume, among other things, that the Company will be able to find buyers for its products. Financial outlook contained in this news release was made by management as of the date of this news release and was provided for the purpose of providing readers with an understanding of the potential revenue which may be derived from supply agreement recently entered into by the Company, and are not an estimate of profitability or any other measure of financial performance. Readers are cautioned that the financial outlook contained in this document should not be used for purposes other than for which it is disclosed herein.